Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bertram

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
The Annals of Otology, Rhinology & Laryngology. Supplement|April 24, 1999
Cochlear implantation in children under the age of two: the MHH experience with the CLARION cochlear implant. Medizinische Hochschule HannoverT Lenarz, A Lesinski-Schiedat, S von der Haar-Heise, et al.
Anticancer Research|July 23, 1998
Chemopreventive effects of dithiocarbamates on aflatoxin B1 metabolism and formation of AFB1 adducts with glutathioneU V Gopalaswamy, E Frei, N Frank, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 17, 2010
[Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs]N Feltgen, A Pielen, L Hansen, et al.
British Journal of Cancer|February 22, 2002
Induction of DNA breaks and apoptosis in crosslink-hypersensitive V79 cells by the cytostatic drug beta-D-glucosyl-ifosfamide mustardR Becker, A Ritter, U Eichhorn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the ratJ Stüben, R Port, B Bertram, et al.
Nutrition and Cancer|January 1, 1993
Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of ratsB L Pool-Zobel, B Bertram, M Knoll, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 3, 2021
[Recommendations of the DGAI, BDA, DOG, BDOC and BVA on anesthesiological care in ophthalmic surgery : In the version from 3 March 2021]R Castello, J Neth, H Hoerauf, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1M Veyhl, K Wagner, C Volk, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]D Pauleikhoff, B Kirchhof, B Bertram, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
The Annals of Otology, Rhinology & Laryngology. Supplement|April 24, 1999
Cochlear implantation in children under the age of two: the MHH experience with the CLARION cochlear implant. Medizinische Hochschule HannoverT Lenarz, A Lesinski-Schiedat, S von der Haar-Heise, et al.
Anticancer Research|July 23, 1998
Chemopreventive effects of dithiocarbamates on aflatoxin B1 metabolism and formation of AFB1 adducts with glutathioneU V Gopalaswamy, E Frei, N Frank, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 17, 2010
[Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs]N Feltgen, A Pielen, L Hansen, et al.
British Journal of Cancer|February 22, 2002
Induction of DNA breaks and apoptosis in crosslink-hypersensitive V79 cells by the cytostatic drug beta-D-glucosyl-ifosfamide mustardR Becker, A Ritter, U Eichhorn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the ratJ Stüben, R Port, B Bertram, et al.
Nutrition and Cancer|January 1, 1993
Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of ratsB L Pool-Zobel, B Bertram, M Knoll, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 3, 2021
[Recommendations of the DGAI, BDA, DOG, BDOC and BVA on anesthesiological care in ophthalmic surgery : In the version from 3 March 2021]R Castello, J Neth, H Hoerauf, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1M Veyhl, K Wagner, C Volk, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]D Pauleikhoff, B Kirchhof, B Bertram, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Pageof 14